Standard InChI: InChI=1S/C23H25F3N2O2/c24-23(25,26)18-9-7-17(8-10-18)16-28-14-12-27(13-15-28)11-3-6-21-19-4-1-2-5-20(19)22(29)30-21/h1-2,4-5,7-10,21H,3,6,11-16H2
1.Xu Q, Hu M, Li J, Ma X, Chu Z, Zhu Q, Zhang Y, Zhu P, Huang Y, He G.. (2022) Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents., 227 [PMID:34710748][10.1016/j.ejmech.2021.113876]
2.Xu Q, Hu M, Li J, Ma X, Chu Z, Zhu Q, Zhang Y, Zhu P, Huang Y, He G.. (2022) Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents., 227 [PMID:34710748][10.1016/j.ejmech.2021.113876]
3.Xu Q, Hu M, Li J, Ma X, Chu Z, Zhu Q, Zhang Y, Zhu P, Huang Y, He G.. (2022) Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents., 227 [PMID:34710748][10.1016/j.ejmech.2021.113876]